GlassScriptPhysician profile
Katiuska Dos Santos
NPI 1346447224
$922.14
in general payments reported to CMS, 2019-2025
14 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.00 · 2020: $57.80 · 2021: $147 · 2022: $198 · 2023: $82.49 · 2024: $188 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $474.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $315.72 | 2020-2025 | Proclaim, Eterna |
| Medtronic, INC. | $171.32 | 2021-2024 | Intellis Adaptivestim |
| Boston Scientific Corporation | $137.59 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Biotronik Nro, INC. | $53.76 | 2025 | Prospera |
| Nevro Corp. | $43.08 | 2019-2021 | |
| Avanos Medical | $42.26 | 2024 | Trivisc Sodium Hyaluronate |
| Medtronic USA, INC. | $37.27 | 2019-2020 | |
| Curonix LLC | $27.98 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $24.71 | 2021 | |
| Bioventus LLC | $16.05 | 2021 | |
| Stimwave Technologies Incorporated | $14.75 | 2022 | |
| Painteq LLC | $13.21 | 2024 | Painteq |
| Arteriocyte Medical Systems, INC. | $12.65 | 2020 | |
| Fidia Pharma USA INC. | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katiuska Dos Santos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.